Aleksandar Jankov, MD, a Baptist Cancer Center oncologist, has completed training to administer Imlygic, a new treatment for melanoma. The therapy is a genetically modified oncolytic for the treatment of unresectable cutaneous, subcutaneous, and nodal lesions in patients with melanoma recurrent after initial surgery. For more information or to schedule a consultation with Dr. Jankov, contact him at aleksandar.jankov@bmg.md.
New Treatment for Melanoma Now Available
Aleksandar Jankov, MD, a Baptist Cancer Center oncologist, has completed training to administer Imlygic, a new treatment for melanoma.
